Condition: Sensorineural Hearing Loss · Bilateral Hearing Loss · Sponsor: Cochlear
A long-term follow-up of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.
This description comes directly from the study's public registry record.
PRS Specialist · +61 2 9428 6555 · cltd-prs-admin@cochlear.com
Always discuss trial participation with your own doctor first.
| Rocky Mountain Ear Center | Englewood, Colorado, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| University Hospitals Cleveland | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06936449